Media release of November 29, 2022
 

Africa investments: Solid fundamentals contrast with low stock valuations
 

Our recent meetings with corporates in our portfolio highlighted the mismatch between their resilient fundamentals and their low valuations as markets overly focus on the macroeconomic headwinds of late. In reality, the latter did not impair the buoyant prospects of our reform-driven investments in Africa which could still post a double-digits earnings growth over the medium term.
 

By Andy Gboka, Portfolio Manager of the Bellevue African Opportunities Fund
 

We met 40 to 50 companies operating across 10 to 15 African countries during our last two business trips that ended in mid-October. It was the right time to discuss business outlook with the management teams given they had a better understanding of the opportunities and challenges ahead, especially after what they went through since the Russia/Ukraine war.

Overall, corporates guided for resilient earnings despite the current inflationary pressures, rising lending costs and devaluation of local currencies vs. the USD. They sounded more confident in the future than what their historically low valuations imply, contrasting with the current sentiment towards African equities which overlooks a more promising growth potential already visible on the ground.

Many African companies are used to operate in a tough business environment
The corporates we invest in built, over the years, a certain resilience against external and domestic shocks helping them deliver commendable results under challenging business conditions. Some of them ended up stronger after a crisis as they consolidated their market shares at the expense of smaller players in the informal economy. These two factors are at play this year and were evident during our discussions.

We also learnt that the extra-saving accumulated since the pandemic helped Egyptian consumers absorb the 30-to-40% price increases vs. 2021, with volumes in the FMCG sector being steady ytd. Obour Land, Egypt’s leading white cheese producer, even posted an impressive 16% volumes growth yoy after its multiple price hikes this first half. In Morocco, some companies in the consumers or healthcare complex were outright bullish, expecting double-digits earnings growth this year and beyond.

Other companies proved their resilience in a challenging year such as 2022 but the most striking example showing that this resilience is sustainable in the long run is Commercial International Bank of Egypt. Looking back at the last 10 years, Egypt went through the Arab spring in 2011/12, the counter revolution in 2013, a big devaluation in late 2016, a period of high inflation in 2017/2018, then the COVID-19 crisis in 2020. Despite all these issues, the bank grew its earnings by 11% every year between 2011 and 2021 in USD terms. Its 12-months profits to June 2022 were well above their levels prior the pandemic and that is also the case for many other holdings in the fund, a performance attesting of their quality in earnings generation.

Long term investors are seizing the opportunity to buy qualitative companies at cheap valuations
A low valuation, earnings resilience and attractive growth outlook are part of the recipe for a re-rating in African equities. Ultimately, markets always catch-up with fundamentals, especially if corporates keep growing their bottom line and the best evidence of it is that some investors saw the opportunities lately.

Since the devaluation in Egypt last March, the sovereign funds of Saudi Arabia, the UAE and Qatar invested billions of USD in names listed on the stock market but also in state-owned enterprises not trading publicly. The same buying spree is undergoing for big conglomerates that have a presence on the continent. Last October, Diageo, the UK-based beer and spirits producer, bid a 40% premium to acquire a 15% stake in its subsidiary East African Breweries. Last September, Crédit Agricole, the French bank, acquired a 5% participation in Crédit Agricole Egypt. In Late 2021, Vitol, the global commodities trader, bid a 25% premium to buyout the minorities in Vivo Energy, a leading fuel distributor in Africa.

We were or still are investors in these three African stocks above and the aforementioned transactions are testament of the high fundamental value embedded in several positions we have in the portfolio.

Morocco remains core to the fund’s long-term investment strategy
Morocco is the nation with the most stable and resilient macroeconomic situation in our universe thanks to the structural reforms implemented over the past 10 to 20 years. This macroeconomic stability allows the Kingdom to focus on sectoral reforms that bring direct opportunities through some listed companies.

Our role as investors in Africa is to access these structural reforms which are growth enablers local companies leverage to grow. This is a key feature of our investment approach and explains Morocco’s high allocation within our portfolio even though local equities’ performance this year is underwhelming. We are not overly concerned by short-term corrections on the market as we are confident the structural growth themes we hold in the portfolio will continue to deliver strong and sustainable earnings growth.

Our last business trip backed up our core investment ideas in Morocco
A theme that came up frequently during our ground visit in October was the healthcare sector reforms in Morocco. Around 21% of the population have a health insurance today and the government’s goal is to move this rate to 70% by 2024. This should allow more Moroccans to access a wider range of pharmaceutical products and healthcare services.

Sothema, the leading pharmaceutical group in Morocco, is well positioned to thrive once these reforms are voted into law. We invested in the company last year, first, because it is likely to benefit from the expected pick-up in drugs demand post reforms. Second, because Sothema has the knowhow and size to contribute to Morocco’s drugs self-sufficiency. In fact, at the height of the COVID-19 crisis, Sothema played a critical role in supplying locally insulin and other medicines when their global availability was low.

Another interesting theme often mentioned in our meetings with local stakeholders was the acceleration of the retail sector formalization. Indeed, the leading retailers recently combined a large portion of their assets into external vehicles run by independent managers to optimize their balance sheet and fund their growth at better conditions. Aradei Capital is the property manager for the majority of the stores operated by the second largest retailer in Morocco, LabelVie. As a result, Aradei should enjoy the strong growth prospects of the formal retail industry but what makes Aradei an interesting case is the fact that it also provides an exposure to other structural themes. The healthcare sector reform is one of them as last year, Aradei set up a Joint Venture with Akdital which is the largest private hospital operator in Morocco. Akdital will rent and operate the 7-to-8 hospitals Aradei should build across the country by 2024 for a total investment of USD 100 mn.

 

Contact

Bellevue Asset Management AG, Seestrasse 16 / P.O. Box, CH-8700 Küsnacht/Zurich,

Tanja Chicherio, tel. +41 44 267 67 09, tch@bellevue.ch

 

www.bellevue.ch

 

Bellevue – Excellence in Specialty Investments 

Bellevue is a specialized asset manager listed on the SIX Swiss Exchange with core competencies covering healthcare strategies, entrepreneur strategies, alternative and traditional investment strategies. Established in 1993, Bellevue, a House of Investment Ideas staffed by 100 professionals, generates attractive investment returns and creates value added for clients and shareholders alike. Bellevue managed assets of CHF 9.8 bn as at June 30, 2022.

 

Disclaimer: This document is neither directed to, nor intended for distribution or use by, any person or entity who is a citizen or resident of any locality, state, country or jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation. The information and data presented in this document are not to be considered as an offer to buy or sell or an invitation to subscribe any securities or financial instruments. The information, opinions and estimates contained in this document reflect a judgment at the original date of release and are subject to change without notice. Liability for the accuracy or completeness of all information in this document is expressly disclaimed. This information does not take into account the specific or future investment objectives, the financial or tax situation or the particular needs of any specific recipient This document does not constitute independent investment research. Interested investors should always seek professional advice before making an investment decision. The information in this document is provided without any guarantees or warranties, for information purposes only, and is intended only for the personal use of the recipient. Every investment involves some risk, especially with regard to of fluctuations in value and return. Investments in foreign currency involve the additional risk that a foreign currency might lose value against an investor's reference currency. This document does not reflect all possible risk factors associated with an investment in the aforementioned securities or financial instruments. Historical performance data and financial market scenarios are no guarantee or indicator of current and future performance. The performance data are calculated without taking account of commissions and costs that result from subscriptions and redemptions. Commissions and costs adversely affect performance. Financial transactions should only be carried out after thorough study of the current prospectus and are only valid on the basis of/or/and are subject to the terms given in the most recently published prospectus and annual or semi-annual report. Bellevue Funds (Lux) SICAV is admitted for public distribution in Switzerland. Representative in Switzerland: Waystone Fund Services (Switzerland) SA, Avenue Villamont 17, CH-1005 Lausanne. Paying Agent in Switzerland: DZ PRIVATBANK (Schweiz) AG, Münsterhof 12, P.O. Box, CH-8022 Zurich. Bellevue Funds (Lux) SICAV is admitted for public distribution in Austria. Paying and information agent: ERSTE BANK der oesterreichischen Sparkassen AG, Am Belvedere 1, A-1100 Vienna. The Bellevue Funds (Lux) SICAV is admitted for public distribution in Germany. Paying and information agent: ACOLIN Europe GmbH, Reichenaustrasse 11a-c, D-78467 Constance. Bellevue Funds (Lux) SICAV is registered in the CNMV registry of foreign collective investment schemes distributed in Spain, under registration number 938. Representative: atl Capital, Calle de Montalbán 9, ES-28014 Madrid. Prospectus, Key Investor Information Document (“KIID”), the articles of association as well as the annual and semi-annual reports of the Bellevue Funds under Luxembourg law are available free of charge from the above mentioned representative, paying, facilities and information agents as well as from Bellevue Asset Management AG, Seestrasse 16, CH-8700 Kusnacht. With respect to fund units distributed in or from Switzerland, the place of performance and jurisdiction is established at the registered office of the representative.